172 related articles for article (PubMed ID: 24680820)
1. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.
Shearer K; Maskew M; Ajayi T; Berhanu R; Majuba P; Sanne I; Fox MP
Int J Infect Dis; 2014 Jun; 23():56-62. PubMed ID: 24680820
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of sexually transmitted infections among adult HIV-positive patients receiving antiretroviral therapy at Themba Lethu HIV clinic in Johannesburg, South Africa.
Onoya D; Manjengwa P; Nattey C; Kgowedi S; Mbele M; Shumba K; Fox MP
S Afr Med J; 2020 Dec; 111(1):80-86. PubMed ID: 33404011
[TBL] [Abstract][Full Text] [Related]
4. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa.
Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P
Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
6. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
Gebo KA; Kalyani R; Moore RD; Polydefkis MJ
J Acquir Immune Defic Syndr; 2005 Oct; 40(2):169-74. PubMed ID: 16186734
[TBL] [Abstract][Full Text] [Related]
7. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.
Nacher M; Basurko C; Adenis A; Gaubert-Marechal E; Mosnier E; Edouard S; Vantilcke V; Sivapregassam S; Tressières B; Cabié A; Couppié P
PLoS One; 2013; 8(11):e80187. PubMed ID: 24244647
[TBL] [Abstract][Full Text] [Related]
9. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.
Clouse K; Pettifor A; Maskew M; Bassett J; Van Rie A; Gay C; Behets F; Sanne I; Fox MP
AIDS; 2013 Feb; 27(4):645-50. PubMed ID: 23169326
[TBL] [Abstract][Full Text] [Related]
10. Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons.
Pomerantz HS; Xu X; White J; Sunil TS; Deiss RG; Ganesan A; Agan BK; Okulicz JF
AIDS Res Ther; 2018 Dec; 15(1):25. PubMed ID: 30537970
[TBL] [Abstract][Full Text] [Related]
11. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.
Evans D; Hirasen K; Berhanu R; Malete G; Ive P; Spencer D; Badal-Faesen S; Sanne IM; Fox MP
AIDS Res Ther; 2018 Apr; 15(1):10. PubMed ID: 29636106
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.
Jansen K; Haastert B; Michalik C; Guignard A; Esser S; Dupke S; Plettenberg A; Skaletz-Rorowski A; Brockmeyer NH
BMC Infect Dis; 2013 Aug; 13():372. PubMed ID: 23937603
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection.
Domingo P; Torres OH; Ris J; Vazquez G
Am J Med; 2001 Jun; 110(8):605-9. PubMed ID: 11382367
[TBL] [Abstract][Full Text] [Related]
15. The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa.
Shearer K; Brennan AT; Maskew M; Long L; Berhanu R; Sanne I; Fox MP
J Int AIDS Soc; 2014; 17(1):19065. PubMed ID: 25361827
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
Van Rie A; Westreich D; Sanne I
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
[TBL] [Abstract][Full Text] [Related]
17. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
[TBL] [Abstract][Full Text] [Related]
18. The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa.
Shearer K; Fox MP; Maskew M; Berhanu R; Long L; Sanne I
PLoS One; 2013; 8(8):e71719. PubMed ID: 23940782
[TBL] [Abstract][Full Text] [Related]
19. Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.
Tovar Salazar A; McKhann A; Chen H; Bosch RJ; Weinberg A
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):890-895. PubMed ID: 31179712
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study.
Glesby MJ; Hoover DR; Tan T; Shi Q; Gao W; French AL; Maurer T; Young M; Dehovitz J; Ru J; Anastos K
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1604-9. PubMed ID: 15577417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
